The emerging role of myeloid-derived suppressor cells in lung diseases. Issue 3 (4th February 2016)

• Record Type: Journal Article
• Authors: Kolahian, Saeed; Öz, Hasan Halit; Zhou, Benyuan; Griessinger, Christoph M.; Rieber, Nikolaus; Hartl, Dominik
• Is Part Of: European respiratory journal. Volume 47:Issue 3(2016)
• Page Start: 967
• Page End: 977
• Publication Date: 2016-02-04
• Subjects: Respiratory organs -- Diseases -- Periodicals; Respiration -- Periodicals; 616.2
• DOI: 10.1183/13993003.01572-2015
• Languages: English
• ISSNs: 0903-1936

Abstract

Myeloid-derived suppressor cells (MDSCs) are innate immune cells characterised by their potential to control T-cell responses and to dampen inflammation. While the role of MDSCs in cancer has been studied in depth, our understanding of their relevance for infectious and inflammatory disease conditions has just begun to evolve. Recent studies highlight an emerging and complex role for MDSCs in pulmonary diseases. In this review, we discuss the potential contribution of MDSCs as biomarkers and therapeutic targets in lung diseases, particularly lung cancer, tuberculosis, chronic obstructive pulmonary disease, asthma and cystic fibrosis. Myeloid-derived suppressor cells are involved in various lung diseases and represent promising therapeutic targets http://ow.ly/WKZKh